BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21169285)

  • 1. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning.
    Ashraf H; Dirksen A; Loft A; Bertelsen AK; Bach KS; Hansen H; Pedersen JH; Mortensen J
    Thorax; 2011 Apr; 66(4):315-9. PubMed ID: 21169285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals.
    Heuvelmans MA; Oudkerk M; de Bock GH; de Koning HJ; Xie X; van Ooijen PM; Greuter MJ; de Jong PA; Groen HJ; Vliegenthart R
    Eur Radiol; 2013 Jul; 23(7):1836-45. PubMed ID: 23508275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
    Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
    Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT.
    Ohno Y; Koyama H; Matsumoto K; Onishi Y; Takenaka D; Fujisawa Y; Yoshikawa T; Konishi M; Maniwa Y; Nishimura Y; Ito T; Sugimura K
    Radiology; 2011 Feb; 258(2):599-609. PubMed ID: 21273522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
    Veronesi G; Bellomi M; Mulshine JL; Pelosi G; Scanagatta P; Paganelli G; Maisonneuve P; Preda L; Leo F; Bertolotti R; Solli P; Spaggiari L
    Lung Cancer; 2008 Sep; 61(3):340-9. PubMed ID: 18308420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography in the diagnostic work-up of screening-detected lung nodules.
    Veronesi G; Travaini LL; Maisonneuve P; Rampinelli C; Bertolotti R; Spaggiari L; Bellomi M; Paganelli G
    Eur Respir J; 2015 Feb; 45(2):501-10. PubMed ID: 25261326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.
    Veronesi G; Maisonneuve P; Bellomi M; Rampinelli C; Durli I; Bertolotti R; Spaggiari L
    Ann Intern Med; 2012 Dec; 157(11):776-84. PubMed ID: 23208167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The volume and mass growth of persisted pulmonary nodules detected in low-dose CT screening and its influence factors].
    Sun Q; Huang Y; Zhao SJ; Zhang L; Tang W; Jin YJ; Wu N
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):274-279. PubMed ID: 29730914
    [No Abstract]   [Full Text] [Related]  

  • 10. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening.
    Veronesi G; Bellomi M; Veronesi U; Paganelli G; Maisonneuve P; Scanagatta P; Leo F; Pelosi G; Travaini L; Rampinelli C; Trifirò G; Sonzogni A; Spaggiari L
    Ann Thorac Surg; 2007 Sep; 84(3):959-65; discussion 965-6. PubMed ID: 17720408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.
    Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A
    Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
    Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
    Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
    Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early lung cancer detection using spiral computed tomography and positron emission tomography.
    Bastarrika G; García-Velloso MJ; Lozano MD; Montes U; Torre W; Spiteri N; Campo A; Seijo L; Alcaide AB; Pueyo J; Cano D; Vivas I; Cosín O; Domínguez P; Serra P; Richter JA; Montuenga L; Zulueta JJ
    Am J Respir Crit Care Med; 2005 Jun; 171(12):1378-83. PubMed ID: 15790860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
    Brady MJ; Thomas J; Wong TZ; Franklin KM; Ho LM; Paulson EK
    Radiology; 2009 Feb; 250(2):523-30. PubMed ID: 19188319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
    O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
    J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating PET and CT information to improve diagnostic accuracy for lung nodules: A semiautomatic computer-aided method.
    Nie Y; Li Q; Li F; Pu Y; Appelbaum D; Doi K
    J Nucl Med; 2006 Jul; 47(7):1075-80. PubMed ID: 16818939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging.
    Stolzmann P; Veit-Haibach P; Chuck N; Rossi C; Frauenfelder T; Alkadhi H; von Schulthess G; Boss A
    Invest Radiol; 2013 May; 48(5):241-6. PubMed ID: 23070096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.